EE05099B1 - Bradkardiaalsete toimeainete kasutamine hpertroofiaga seotud mokardiaalsete haiguste ravimiseks ja ravimikombinatsioonid - Google Patents

Bradkardiaalsete toimeainete kasutamine hpertroofiaga seotud mokardiaalsete haiguste ravimiseks ja ravimikombinatsioonid

Info

Publication number
EE05099B1
EE05099B1 EEP200200590A EEP200200590A EE05099B1 EE 05099 B1 EE05099 B1 EE 05099B1 EE P200200590 A EEP200200590 A EE P200200590A EE P200200590 A EEP200200590 A EE P200200590A EE 05099 B1 EE05099 B1 EE 05099B1
Authority
EE
Estonia
Prior art keywords
cardiac
pertrophia
brad
treatment
disorders associated
Prior art date
Application number
EEP200200590A
Other languages
English (en)
Inventor
D�mmgen J�rgen
Guth Brian
Seidler Randolph
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of EE200200590A publication Critical patent/EE200200590A/et
Publication of EE05099B1 publication Critical patent/EE05099B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EEP200200590A 2000-04-13 2001-04-07 Bradkardiaalsete toimeainete kasutamine hpertroofiaga seotud mokardiaalsete haiguste ravimiseks ja ravimikombinatsioonid EE05099B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10018401A DE10018401A1 (de) 2000-04-13 2000-04-13 Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
PCT/EP2001/004034 WO2001078699A2 (de) 2000-04-13 2001-04-07 Verwendung von bradycardica bei der behandlung von mit hypertrophie einhergehenden myocarderkrankungen und neue arzneimittelkombinationen

Publications (2)

Publication Number Publication Date
EE200200590A EE200200590A (et) 2004-04-15
EE05099B1 true EE05099B1 (et) 2008-12-15

Family

ID=7638652

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200590A EE05099B1 (et) 2000-04-13 2001-04-07 Bradkardiaalsete toimeainete kasutamine hpertroofiaga seotud mokardiaalsete haiguste ravimiseks ja ravimikombinatsioonid

Country Status (33)

Country Link
US (2) US7208508B2 (et)
EP (2) EP1276476B1 (et)
JP (1) JP3905386B2 (et)
KR (1) KR20020089453A (et)
CN (1) CN1245963C (et)
AT (1) ATE330588T1 (et)
AU (2) AU2001270484B2 (et)
BG (1) BG65816B1 (et)
BR (1) BR0109996A (et)
CA (2) CA2575059A1 (et)
CY (1) CY1105081T1 (et)
CZ (1) CZ300549B6 (et)
DE (2) DE10018401A1 (et)
DK (1) DK1276476T3 (et)
EA (1) EA006977B1 (et)
EE (1) EE05099B1 (et)
ES (1) ES2266216T3 (et)
HR (1) HRP20020815A2 (et)
HU (1) HU228387B1 (et)
IL (2) IL152103A0 (et)
ME (1) MEP45908A (et)
MX (1) MXPA02009935A (et)
NO (1) NO330311B1 (et)
NZ (1) NZ521934A (et)
PL (1) PL215235B1 (et)
PT (1) PT1276476E (et)
RS (1) RS51478B (et)
SI (1) SI1276476T1 (et)
SK (1) SK286075B6 (et)
TR (1) TR200202326T2 (et)
UA (1) UA78679C2 (et)
WO (1) WO2001078699A2 (et)
ZA (1) ZA200208162B (et)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10018401A1 (de) 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
US20040138306A1 (en) * 2002-07-25 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
PT1362590E (pt) * 2002-07-25 2004-05-31 Boehringer Ingelheim Pharma Utilizacao de cilobradina ou dos seus sais farmaceuticamente aceitaveis para o tratamento ou prevencao de falha cardiaca
JP3874419B2 (ja) * 2003-01-31 2007-01-31 三共株式会社 動脈硬化及び高血圧症の予防及び治療のための医薬
EP1898951B1 (en) * 2005-06-27 2013-02-27 Daiichi Sankyo Company, Limited Pharmaceutical preparation containing an angiotensin ii receptor antagonist and a calcium channel blocker
CA2617519A1 (en) * 2005-08-23 2007-03-01 Astellas Pharma Inc. Agent for treating atrial fibrillation
EP1762179A1 (en) 2005-09-07 2007-03-14 Boehringer Ingelheim Vetmedica Gmbh Method for improving diagnostic quality in echocardiography
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
TWI399223B (zh) * 2006-09-15 2013-06-21 Daiichi Sankyo Co Ltd 奧美沙坦酯及氨氯地平之固體劑型
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
ES2598490T3 (es) 2009-05-20 2017-01-27 Boehringer Ingelheim Vetmedica Gmbh Disolución farmacéutica bebible de telmisartán
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
KR101296743B1 (ko) * 2011-02-17 2013-08-20 한국과학기술연구원 심근 비대증 진단용 바이오마커 및 이를 이용한 심근 비대증 진단 방법
JP2014521713A (ja) * 2011-08-12 2014-08-28 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング 味をマスキングした医薬組成物
EP2953612A1 (en) 2013-02-11 2015-12-16 Boehringer Ingelheim Vetmedica GmbH Kit-of-parts
DK3648761T3 (da) 2017-07-07 2024-06-24 Boehringer Ingelheim Vetmedica Gmbh Telmisartan til forebyggelsen eller behandlingen af hypertension i katte
KR102398532B1 (ko) 2020-07-20 2022-05-13 한림대학교 산학협력단 중증 지주막하출혈 진단용 조성물
KR102331806B1 (ko) 2020-07-20 2021-12-01 한림대학교 산학협력단 중증 지주막하출혈 진단용 바이오 마커

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759125A (fr) 1969-11-19 1971-05-18 Boehringer Sohn Ingelheim Nouvelles n-allyl-2-arylamino-imidazolines-(2) substituees et procedes pour les fabriquer
DE3119874A1 (de) 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3541811A1 (de) * 1985-11-27 1987-06-04 Thomae Gmbh Dr K Neue cyclische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5175157A (en) * 1985-11-27 1992-12-29 Boehringer Ingelheim Gmbh Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
DE3736866A1 (de) * 1987-10-30 1989-05-11 Thomae Gmbh Dr K Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
DE3805635A1 (de) 1988-02-24 1989-09-07 Thomae Gmbh Dr K Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
US5308853A (en) * 1991-12-20 1994-05-03 Warner-Lambert Company Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties
RU2078536C1 (ru) * 1993-09-02 1997-05-10 Украинский научно-исследовательский институт кардиологии им.акад.Н.Д.Стражеско Способ определения клинической эффективности применения верапамила и дилтиазема у больных гипертрофической кардиомиопатией
BR9407613A (pt) * 1993-09-24 1997-01-14 Procter & Gamble Novos compostos deoxi e 14-amino esteróide contendo açúcar substituído com oxigênio
US5595987A (en) * 1994-07-22 1997-01-21 The Trustees Of Columbia University In The City Of New York Method of slowing ventricular arrhythmias using zatebradine
US6083991A (en) * 1997-06-04 2000-07-04 University Of Florida Research Foundation, Inc. Anti-arrhythmic composition and methods of treatment
DE19741635A1 (de) * 1997-09-22 1999-03-25 Hoechst Marion Roussel De Gmbh Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
CN1234357C (zh) * 1998-07-10 2006-01-04 诺瓦提斯公司 缬沙坦和钙通道阻断剂的抗超敏组合
DE10018401A1 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
CA2435526A1 (en) 2002-07-25 2004-01-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of cyclic amine derivatives or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
US20040138306A1 (en) * 2002-07-25 2004-07-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
EP1762179A1 (en) * 2005-09-07 2007-03-14 Boehringer Ingelheim Vetmedica Gmbh Method for improving diagnostic quality in echocardiography

Also Published As

Publication number Publication date
ES2266216T3 (es) 2007-03-01
NO20024924L (no) 2002-10-11
DK1276476T3 (da) 2006-08-14
US20040014795A1 (en) 2004-01-22
IL152103A0 (en) 2003-07-31
JP2003535050A (ja) 2003-11-25
BR0109996A (pt) 2003-05-27
EP1666042A3 (de) 2006-06-21
AU2001270484B2 (en) 2007-01-25
NO20024924D0 (no) 2002-10-11
HUP0300917A2 (hu) 2003-08-28
CN1245963C (zh) 2006-03-22
YU76902A (sh) 2006-05-25
CA2404120C (en) 2008-01-22
EA200201053A1 (ru) 2003-02-27
DE10018401A1 (de) 2001-10-25
EA006977B1 (ru) 2006-06-30
SK286075B6 (sk) 2008-03-05
NZ521934A (en) 2007-05-31
KR20020089453A (ko) 2002-11-29
CA2404120A1 (en) 2001-10-25
AU7048401A (en) 2001-10-30
TR200202326T2 (tr) 2003-03-21
DE50110262D1 (de) 2006-08-03
BG65816B1 (bg) 2010-01-29
MXPA02009935A (es) 2003-02-12
CY1105081T1 (el) 2009-11-04
HU228387B1 (en) 2013-03-28
IL152103A (en) 2008-07-08
WO2001078699A3 (de) 2002-06-20
SI1276476T1 (sl) 2006-10-31
CZ20023752A3 (cs) 2003-03-12
UA78679C2 (en) 2007-04-25
WO2001078699A2 (de) 2001-10-25
CN1422153A (zh) 2003-06-04
BG107103A (bg) 2003-04-30
MEP45908A (en) 2011-02-10
US7208508B2 (en) 2007-04-24
JP3905386B2 (ja) 2007-04-18
US20070155679A1 (en) 2007-07-05
EE200200590A (et) 2004-04-15
NO330311B1 (no) 2011-03-28
ZA200208162B (en) 2003-10-17
HRP20020815A2 (en) 2004-12-31
PT1276476E (pt) 2006-09-29
CA2575059A1 (en) 2001-10-25
ATE330588T1 (de) 2006-07-15
HUP0300917A3 (en) 2009-04-28
PL215235B1 (pl) 2013-11-29
EP1276476B1 (de) 2006-06-21
EP1666042A2 (de) 2006-06-07
PL357827A1 (en) 2004-07-26
RS51478B (sr) 2011-04-30
CZ300549B6 (cs) 2009-06-10
EP1276476A2 (de) 2003-01-22
SK14582002A3 (sk) 2003-03-04

Similar Documents

Publication Publication Date Title
EE05099B1 (et) Bradkardiaalsete toimeainete kasutamine hpertroofiaga seotud mokardiaalsete haiguste ravimiseks ja ravimikombinatsioonid
ES2357559T3 (es) Derivados de alfa-aminoamida útiles en el tratamiento de trastornos adictivos.
AU2005202257C1 (en) Azacyclic compounds for use in the treatment of serotonin related diseases
TW200505901A (en) Muscarinic agonists
BR0014525A (pt) Processo de tratamento de distúrbios metabólicos, especialmente diabetes, ou uma doença ou condição associada com diabetes
EE05315B1 (et) Dapoksetiini v?i selle farmatseutiliselt vastuv?etava soola kasutamine ravimi valmistamiseks, mis on ette n„htud imetajal esineva seksuaalse funktsioonih„ire ravimiseks v?i m?jutamiseks
HK1044333A1 (zh) 趨化因子受體拮抗劑及其使用方法
WO2002053101A3 (en) Method for treating fibrotic diseases or other indications
GB2352972A (en) Use of dexmedetomidine for icu sedation
BR9910899A (pt) Compostos de ácido sulfÈnico ou sulfonilamino n-(hetero-aralquil)-azaeterocicliamida
SORSCHER et al. Antidepressant-induced sexual dysfunction in men: Due to cholinergic blockade?
BR0111982A (pt) Tratamento com apomorfina, de disfunção sexual induzida por droga anti depressão
BR0108261A (pt) Uso de mirtazapina, método de tratamento de um distúrbio do sono em um indivìduo, e, kit para paciente para o tratamento de distúrbios do sono
WO2000076500A8 (en) Compound for use as a medicament for treatment of disorders involving bronchocontraction
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea
HK1064036A1 (en) Kapp-opiate agonists for the treatment of bladder dieseases
US6214849B1 (en) Use of nicorandil in treatment of sexual dysfunction or for enhancement of sexual function in mammals including humans
EP1632235A3 (en) Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders
PL1514545T3 (pl) Zastosowanie tolperyzonu do leczenia skurczów narządów zbudowanych zasadniczo z mięśni gładkich
EP1787984A3 (en) Azacyclic compounds for use in the treatment of serotonin related diseases

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20160407